Fermenbio Profit & Loss Annual

Trade
BSE: 506414 | NSE: - | ISIN: INE225B01021 | Sector: Biotechnology & Drugs
370.75 +44.60 (13.67%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 335.66349.94398.52377.29
Total Revenue 335.66349.94398.52377.29
Costof Revenue Total 130.14181.66185.21157.29
Gross Profit 205.52168.29213.30220.00
Selling/ General/ Admin Expenses Total 58.5592.3895.4890.03
Depreciation/ Amortization 24.7225.6522.7317.75
Unusual Expense( Income) 7.4328.480.000.00
Other Operating Expenses Total 119.4657.2456.3447.05
Total Operating Expense 340.30388.00362.60314.67
Operating Income -4.64-38.0635.9262.62
Interest Inc( Exp) Net- Non- Op Total -170.46-166.11-135.28-99.71
Other Net 11.813.114.58-0.86
Net Income Before Taxes -9.87-51.8726.9451.63
Provisionfor Income Taxes 14.141.6811.889.10
Net Income After Taxes -24.01-53.5515.0642.53
Minority Interest 0.952.060.392.98
Equity In Affiliates 0.00-0.000.00
Net Income Before Extra Items -23.06-51.5015.4545.51
Net Income -23.06-51.5015.4545.51
Income Availableto Com Excl Extra Ord -23.06-51.5015.4545.51
Income Availableto Com Incl Extra Ord -23.06-51.5015.4545.51
Diluted Net Income -23.06-51.5015.4545.51
Diluted Weighted Average Shares 2.892.892.902.90
Diluted EPS Excluding Extra Ord Items -7.99-17.855.3315.69
DPS- Common Stock Primary Issue 1.251.251.252.50
Diluted Normalized EPS -6.32-11.365.3315.73
Interest Exp( Inc) Net- Operating Total -26.0028.3625.58
Gain( Loss)on Saleof Assets --3.15-0.27-1.60
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts